Rockefeller Capital Management
TENX icon

Rockefeller Capital Management’s Tenax Therapeutics TENX Stock Holding History

Rockefeller Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15 Sell
1
-2,500
-100% -$31.9K ﹤0.01% 4713
2026
Q1 		$40K Buy
2,501
+2,500
+250,000% +$33.8K ﹤0.01% 3393
2025
Q4 		$12 Sell
1
-1
-50% -$9 ﹤0.01% 4658
2025
Q3 		$15 Buy
+2
New +$12 ﹤0.01% 4411

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Rockefeller Capital Management's TENX Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Tenax Therapeutics (TENX) stake by 100% in Q2 2026, selling an estimated $31.9K and leaving 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #4713.

Rockefeller Capital Management first reported a position in TENX in Q3 2025 and has held it in 4 quarters since. The position peaked at $40K in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Rockefeller Capital Management held 1 share of Tenax Therapeutics worth $15 as of Q2 2026.
  • Rockefeller Capital Management sold 2,500 Tenax Therapeutics shares in Q2 2026, an estimated $31.9K.
  • Tenax Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4713 holding.
  • Rockefeller Capital Management first reported a position in Tenax Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Tenax Therapeutics position peaked at $40K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.